top of page

General Critical Care

Public·386 members

A new a agent (MV140: a sublingual preparation of whole-cell inactivated bacteria) was studied in a controlled trial of modest size and duration, and showed promising clinical efficacy in reducing recurrent UTI in women suffering from this condition.

  • Mouhmad Jamil


    This is a vibrant, inclusive, and interactive space for heal...

    bottom of page